Physician profile
Nicole Laing
NPI 1639552417
$2,983.46
in general payments reported to CMS, 2019-2025
30 companies · $19.13 in 2025
The $19.13 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $141 · 2022: $1,631 · 2023: $840 · 2024: $352 · 2025: $19.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,211.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,211.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $1,661.52 | 2022-2023 | Venclose Maven Catheter |
| Tactile Systems Technology INC | $158.85 | 2022-2023 | Entre Plus, Flexitouch Plus |
| Alnylam Pharmaceuticals INC. | $80.26 | 2023-2024 | Onpattro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $68.22 | 2023-2024 | Jardiance |
| Edwards Lifesciences Corporation | $64.58 | 2023-2024 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abbott Laboratories | $63.04 | 2021-2025 | Octrode |
| E.R. Squibb & Sons, L.L.C. | $60.97 | 2023-2024 | Camzyos, Eliquis |
| Kiniksa Pharmaceuticals, LTD. | $60.78 | 2023 | Arcalyst |
| Medtronic, INC. | $59.56 | 2023-2024 | Venaseal |
| Baxter Healthcare | $58.09 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Pfizer INC. | $57.92 | 2023-2024 | |
| Amgen INC. | $53.20 | 2023 | Repatha |
| Kestra Medical Technology Services, INC. | $52.37 | 2023 | Assure Wcd |
| Astrazeneca Pharmaceuticals LP | $47.23 | 2024 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $44.05 | 2023 | Lifevest |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $43.06 | 2023-2024 | Injectafer |
| Novartis Pharmaceuticals Corporation | $41.56 | 2023-2024 | |
| Impulse Dynamics (USA) INC. | $38.27 | 2023 | Optimizer |
| Merck Sharp & Dohme LLC | $35.85 | 2023 | Verquvo |
| Janssen Pharmaceuticals, INC | $30.91 | 2021 | |
| Ge Healthcare | $28.91 | 2021-2022 | |
| Abiomed | $25.44 | 2024 | Impella |
| Regeneron Healthcare Solutions, INC. | $22.63 | 2023 | Evkeeza |
| Heartflow, INC. | $22.29 | 2024 | |
| Silk Road Medical, INC. | $21.52 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $20.84 | 2024 | |
| Kiniksa Pharmaceuticals International, Plc | $16.40 | 2024 | Arcalyst |
| Boston Scientific Corporation | $15.57 | 2021 | |
| Siemens Medical Solutions USA, INC. | $15.22 | 2021 | |
| Scpharmaceuticals INC. | $14.35 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Laing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.